Navigation Links
ZyGEM Releases Data Confirming Its prepGEM(R) Bacteria Kit Is a Simple, Universal Method for Extracting DNA from Different Bacteria Species

SOLANA BEACH, Calif. and HAMILTON, New Zealand, July 9 /PRNewswire/ -- ZyGEM Corp. Ltd., a provider of innovative enzyme-based products for DNA extraction and other life sciences applications, today announced the availability of a new application note documenting that its prepGEM(R) Bacteria DNA extraction kit is capable of producing high quality, ready-to-analyze DNA from a broad range of bacterial species, including mixed or unknown sample types. This addresses an important unmet need --current DNA extraction methods typically require the use of different enzymes for each type of bacteria tested. The prepGEM(R) Bacteria kit also uses a single closed-tube system that reduces extraction time and cost while protecting the sample from contamination and making the kit easily adaptable for automation.

The prepGEM(R) Bacteria kit is extremely versatile -- data in the application note confirms that it can extract DNA from bacterial species in samples containing multiple and unknown species. This versatility results from the kit's unique combination of enzymes that become active at different temperatures, providing the capability for multiple reactions in a single processing run. Data in the application note also demonstrates that prepGEM(R) Bacteria can process low-volume samples containing low numbers of cells, allowing researchers to extract DNA directly from these samples without first having to conduct a concentration step, thereby significantly simplifying and speeding up the procedure.

"Data in the new prepGEM(R) Bacteria application note confirms that our kits easily and rapidly extract DNA from sample types that typically pose problems for scientists, often requiring multiple steps that increase the time and cost of DNA extraction, while also increasing the risk of contamination," said Paul Kinnon, CEO of ZyGEM. "The molecular detection of microbes offers major advantages over conventional approaches, yet the lack of a universal DNA extraction method has been a barrier to wider adoption of molecular-based technologies. The speed and ease-of-use afforded by our prepGEM(R) Bacteria kit allows for rapid DNA-based detection and monitoring of different bacteria strains efficiently and reproducibly, without significant investment of time or hardware. These important advantages make the prepGEM(R) Bacteria kit valuable for diverse applications, including infectious disease diagnosis and pathogen monitoring in a variety of settings, such as vaccine development and quality control."

In the application note, ZyGEM researchers describe their experience using prepGEM(R) Bacteria to extract DNA from a single sample of mixed bacteria containing Gram positive, Gram negative and polysaccharide-secreting bacterial species that would typically require separate extraction procedures. The prepGEM(R) Bacteria kit extracted PCR-ready DNA from this diverse sample with a single temperature-controlled reaction using its unique combination of thermophilic enzymes and a buffer with proprietary agents that enhance cell lysis. Results showed that prepGEM(R) Bacteria's simple, two-step reaction in a single closed tube efficiently extracted high quality DNA from diverse bacteria sample types, greatly reducing the risk of contamination and providing a method that is easily adaptable for automation.

ZyGEM researchers also successfully extracted quality PCR-ready DNA from low-volume samples using prepGEM(R) Bacteria kits, without the need for the concentration step that is often required before extracting DNA from small samples. This simplifies and speeds up the procedure while also reducing the possibility of sample contamination during the concentration process.

The prepGEM(R) Bacteria kit is compatible with all PCR detection and amplification reagents, and the stability of the prepGEM(R) reagents allows convenient storage at 4 degrees C, reducing preparation time and increasing ease of use.

ZyGEM offers a growing number of application notes for its prepGEM(R), forensicGEM(R) and livestockGEM(R) families of kits. ZyGEM application notes can be accessed at

ZyGEM's proprietary technology uses a thermophilic enzyme to extract DNA from samples using a single closed-tube system. ZyGEM's approach significantly reduces the time and cost of DNA extractions while simplifying laboratory workflow, minimizing error, reducing the risk of contamination, ensuring sample integrity and facilitating extractions from trace samples. It is easily adaptable for use with virtually all off-the-shelf laboratory automation systems. The technology can be specifically formulated for use with a wide range of different sample types without the need for further purification. ZyGEM's technology has been validated for use in highly regulated applications, including forensic analysis. For more information on ZyGEM's families of DNA extraction kits, visit or email

About ZyGEM Corporation

ZyGEM Corporation Limited is a rapidly growing biotechnology company with a range of innovative enzyme-based products and technologies based on the company's exclusive collection of microorganisms from extreme environments. ZyGEM's technology has significant competitive advantages over existing methods and has potential applications in a number of sizeable global markets. ZyGEM currently produces DNA extraction and detection products, molecular biology enzymes and individual enzymes and diagnostics, serving life sciences customers in basic research, forensics, clinical diagnostics and agriculture. ZyGEM has facilities in New Zealand and the U.S.A. For more information, visit

    Paul Kinnon
    President and CEO
    858 720-8333

    GendeLLindheim BioCom Partners
    Jennifer Anderson
    212 918-4642

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CenTrak Releases New Temperature Tag for Healthcare
2. American Society of Anesthesiologists Releases Following Statement Related to Media Inquires Regarding Michael Jacksons Death
3. ISPA Releases 2009 U.S. Spa Industry Statistics
4. Lung Cancer Alliance Releases Updated 2009 Facts About Lung Cancer
5. Pennsylvania Patient Safety Authority Releases June Advisory
6. Releases the Top 20 Most Popular Searches for Patient Assistance Programs
7. Lightspeed Releases the New DepthQ(R) Family of Stereoscopic HD Video Software
8. Denver-Based Acupuncturist, Dr. Martha Lucas, Releases New Book: Vanity Calamity: Your Guide to Cosmetic Acupuncture for Anti-aging
9. U.S. News Media Group Releases Rankings of Americas Best Childrens Hospitals
10. Baxa Corporation Releases IntelliFlowRx(TM) Upgrades
11. T-System Releases 2009 Update for the T System(R) Primary Care Charting System
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... of workshops to discuss bioavailability and the need to integrate dose form selection ... in collaboration with OBN, the membership organization supporting and bringing together the UK’s ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... PRMA Plastic ... November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , ... wake up every day excited to rebuild lives and it’s an honor to have ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios brings Final ... ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, ... giving users limitless opportunities to stylize and create designs quickly and easily, all ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the ... to improve system efficiency and reliability. , The new Q-Suite 6 platform is based ... system avoids locking itself into a specific piece of software for many key components ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
Breaking Medicine Technology: